Celanese Corporation
CE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.01 | 0.75 | 0.00 |
| FCF Yield | 9.69% | 5.23% | -1.05% | 5.14% |
| EV / EBITDA | -3.65 | 36.04 | 51.42 | -16.69 |
| Quality | ||||
| ROIC | -6.52% | 1.72% | 3.22% | -8.56% |
| Gross Margin | 21.54% | 21.13% | 19.92% | 22.74% |
| Cash Conversion Ratio | -0.33 | 2.03 | -2.18 | -0.26 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.24% | -1.17% | 0.23% | 2.05% |
| Free Cash Flow Growth | 41.01% | 587.69% | -116.71% | 4,422.22% |
| Safety | ||||
| Net Debt / EBITDA | -0.03 | 24.04 | 34.06 | -10.23 |
| Interest Coverage | 7.20 | 1.32 | 0.84 | -8.57 |
| Efficiency | ||||
| Inventory Turnover | 0.86 | 0.87 | 0.83 | 0.80 |
| Cash Conversion Cycle | 143.56 | 113.50 | 117.64 | 113.20 |